Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit
Andrew J. Vickers, Frank O’Brien, Francesco Montorsi, David Galvin, Ola Bratt, Sigrid Carlsson, James W.F. Catto, Agnė Krilavičiūtė, Michael Philbin, Peter Albers
Abstract
Informed choice approaches lead to high rates of unsystematic PSA testing, especially among those least likely to benefit and most likely to be harmed, argue <b>Andrew Vickers and colleagues</b>
Topics & Concepts
OverdiagnosisProstate cancerMedicineCancerPolitical scienceIntensive care medicineEnvironmental healthInternal medicineProstate Cancer Diagnosis and TreatmentColorectal Cancer Screening and DetectionGlobal Cancer Incidence and Screening